Recent Activity

Loading...

MAIA

MAIA Biotechnology, Inc. · AMEX

Performance

+14.53%

1W

+60.68%

1M

+112.18%

3M

+136.43%

6M

+182.91%

YTD

+36.78%

1Y

Profile

MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.

Technical Analysis of MAIA 2024-05-10

Overview:

In analyzing the technical indicators for MAIA stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible future stock price movement. By examining these key indicators, we aim to offer valuable insights and predictions for the upcoming tradin...

See more ...

Recent News & Updates